Rare genetic disease with myoclonus as a major feature

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:307067
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Orphanet code 307067 refers to a rare genetic disease group where myoclonus — sudden, brief, involuntary muscle jerks — is a major defining feature. This category encompasses several rare conditions in which myoclonus significantly affects daily life and neurological function. Myoclonus can range from mild twitches to severe jerking movements that interfere with walking, eating, and other basic activities. These conditions are caused by changes (mutations) in specific genes that affect how the brain and nervous system control movement. Patients with these disorders may experience progressive worsening of myoclonus over time, sometimes accompanied by seizures (epilepsy), difficulty with coordination (ataxia), cognitive decline, or other neurological problems. The severity and combination of symptoms can vary widely depending on the specific underlying genetic cause. Treatment is mainly focused on managing symptoms. Anti-epileptic and anti-myoclonic medications such as valproate, clonazepam, levetiracetam, and piracetam may help reduce the frequency and severity of myoclonic jerks. Physical therapy and occupational therapy can also help maintain function. Currently, there is no cure for most genetic forms of myoclonus, but ongoing research continues to explore new treatment options. Early diagnosis through genetic testing is important for guiding treatment and providing families with accurate information about what to expect.

Key symptoms:

Sudden involuntary muscle jerks (myoclonus)Seizures or epilepsyDifficulty with balance and coordination (ataxia)TremorMuscle stiffness or rigidityDifficulty walkingSlurred speechCognitive decline or intellectual disabilityDifficulty with fine motor tasks like writingVision problemsSensitivity to light or flashing lights triggering jerksProgressive worsening of movement controlDifficulty swallowing

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare genetic disease with myoclonus as a major feature.

View clinical trials →

No actively recruiting trials found for Rare genetic disease with myoclonus as a major feature at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare genetic disease with myoclonus as a major feature community →

No specialists are currently listed for Rare genetic disease with myoclonus as a major feature.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare genetic disease with myoclonus as a major feature.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare genetic disease with myoclonus as a major featureForum →

No community posts yet. Be the first to share your experience with Rare genetic disease with myoclonus as a major feature.

Start the conversation →

Latest news about Rare genetic disease with myoclonus as a major feature

No recent news articles for Rare genetic disease with myoclonus as a major feature.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific genetic subtype of myoclonus does my child or I have, and what does this mean for the future?,Which medications are best for controlling myoclonus, and what side effects should I watch for?,Are there any medications or substances I should avoid that could make the myoclonus worse?,How often should we have follow-up appointments and what tests will be needed over time?,Are there any clinical trials or new treatments being studied for this condition?,What therapies (physical, occupational, speech) would be most helpful right now?,Should other family members be tested for this genetic condition?

Common questions about Rare genetic disease with myoclonus as a major feature

What is Rare genetic disease with myoclonus as a major feature?

Orphanet code 307067 refers to a rare genetic disease group where myoclonus — sudden, brief, involuntary muscle jerks — is a major defining feature. This category encompasses several rare conditions in which myoclonus significantly affects daily life and neurological function. Myoclonus can range from mild twitches to severe jerking movements that interfere with walking, eating, and other basic activities. These conditions are caused by changes (mutations) in specific genes that affect how the brain and nervous system control movement. Patients with these disorders may experience progressive